HUTCHMED (China) (HMDCF) Free Cash Flow Growth (3y) (2021)

HUTCHMED (China) (HMDCF) Free Cash Flow Growth (3y) (2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 9.86%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -18.92%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 2.82%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 45.60%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 39.19%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -82.02%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 114.21%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 18.94%
10 HUTCHMED (China) - - - -

Historic Data

Download Data
DateValue
Jun 30, 2021 -44.25%
Mar 31, 2021 17.96%